Capital International LTD Alnylam Pharmaceuticals, Inc. Transaction History
Capital International LTD
- $2.09 Billion
- Q2 2024
A detailed history of Capital International LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital International LTD holds 94,225 shares of ALNY stock, worth $25.7 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
94,225
Previous 65,224
44.46%
Holding current value
$25.7 Million
Previous $9.75 Million
134.9%
% of portfolio
1.1%
Previous 0.49%
Shares
9 transactions
Others Institutions Holding ALNY
# of Institutions
639Shares Held
107MCall Options Held
2.33MPut Options Held
2.15M-
Capital World Investors Los Angeles, CA15MShares$4.09 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.41 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.61 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.7 Billion0.28% of portfolio
-
Baillie Gifford & CO4.89MShares$1.33 Billion1.03% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...